CIK 0001668243
- Non-accelerated filer
- Smaller reporting company
UroGen Pharma Ltd.
Sign in to watch- Ticker
- URGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 97707601
- Business address
- 9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,037,646
- in 4 filings
Net −$3,037,646. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-22 | BUTITTA CYNTHIA M Director | Grant or award · Restricted Stock Unit | +8,000 | 8,000 | ||
| 2026-06-22 | WEN LEANA Director | Grant or award · Stock Option (right ot buy) | +10,000 | 10,000 | ||
| 2026-06-22 | WEN LEANA Director | Grant or award · Restricted Stock Unit | +8,000 | 8,000 | ||
| 2026-06-22 | Belldegrun Arie Director | Grant or award · Stock Option (right ot buy) | +20,000 | 20,000 | ||
| 2026-06-08 | Schoenberg Mark Chief Medical Officer | Option exercise | +10,000 | 144,985 | ||
| 2026-06-08 | Schoenberg Mark Chief Medical Officer | Sale | −5,222 | $27.30 | $143K | 139,763 |
| 2026-06-08 | Schoenberg Mark Chief Medical Officer | Option exercise · Restricted Stock Units | −10,000 | 0 | ||
| 2026-05-26 | Robinson James A. Jr. Director | Option exercise | +2,000 | 6,000 | ||
| 2026-05-26 | Robinson James A. Jr. Director | Option exercise · Restricted Stock Unit | −2,000 | 2,000 | ||
| 2026-05-08 | Schoenberg Mark Chief Medical Officer | Sale 10b5-1 | −10,000 | $30.00 | $300K | 134,985 |
| 2026-02-03 | Smith Jason Drew General Counsel | Sale | −2,654 | $19.69 | $52K | 52,934 |
| 2026-02-03 | Smith Jason Drew General Counsel | Sale | −1,608 | $19.69 | $32K | 51,326 |
| 2026-02-03 | Smith Jason Drew General Counsel | Sale | −3,217 | $19.69 | $63K | 55,588 |
| 2026-02-03 | Schoenberg Mark Chief Medical Officer | Sale | −1,844 | $19.69 | $36K | 150,514 |
| 2026-02-03 | Schoenberg Mark Chief Medical Officer | Sale | −1,843 | $19.69 | $36K | 148,671 |
| 2026-02-03 | Schoenberg Mark Chief Medical Officer | Sale | −3,686 | $19.69 | $73K | 144,985 |
| 2026-01-31 | Barrett Elizabeth A. Chief Executive Officer | Grant or award · Restricted Stock Units | +153,195 | 153,195 | ||
| 2026-01-31 | Smith Jason Drew General Counsel | Option exercise | +5,500 | 55,472 | ||
| 2026-01-31 | Smith Jason Drew General Counsel | Option exercise | +3,333 | 58,805 | ||
| 2026-01-31 | Smith Jason Drew General Counsel | Option exercise | +6,667 | 49,972 |
Page 2 of 13 · 244 trades